Cargando…

The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review

The story of high mobility group protein B1 (HMGB1) in cancer is complicated and the function of HMGB1 in different cancers is uncertain. This review aims to retrieve literature regarding HMGB1 from English electronic resources, analyze and summarize the role of the HMGB1 signaling pathway in hepato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xuanbin, Xiang, Longchao, Li, Hongliang, Chen, Ping, Feng, Yibin, Zhang, Jingxuan, Yang, Nian, Li, Fei, Wang, Ye, Zhang, Quifang, Li, Fang, Cao, Fengjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613322/ https://www.ncbi.nlm.nih.gov/pubmed/26393575 http://dx.doi.org/10.3390/ijms160922527

Ejemplares similares

Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine
por: Wang, Xuanbin, et al.
Publicado: (2016)

Emodin Induced SREBP1-Dependent and SREBP1-Independent Apoptosis in Hepatocellular Carcinoma Cells
por: Yang, Nian, et al.
Publicado: (2019)

Elevated YKL-40 expression is associated with a poor prognosis in breast cancer patients
por: Wan, Guoxing, et al.
Publicado: (2016)

Pharmacokinetics of Anthraquinones from Medicinal Plants
por: Wang, Dongpeng, et al.
Publicado: (2021)

Icariin Protects Rat Cardiac H9c2 Cells from Apoptosis by Inhibiting Endoplasmic Reticulum Stress
por: Zhang, Qiufang, et al.
Publicado: (2013)

Chinese Medicines for Preventing and Treating Radiation-Induced Pulmonary Injury: Still a Long Way to Go
por: Ding, Yan, et al.
Publicado: (2019)

Association of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression
por: Bi, Man Ru, et al.
Publicado: (2014)

Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2016)

Dissection of HY5/HYH expression in Arabidopsis reveals a root-autonomous HY5-mediated photomorphogenic pathway
por: Zhang, Yonghong, et al.
Publicado: (2017)

Bevacizumab Added to Neoadjuvant Chemotherapy in HER2-Negative Non-Metastatic Breast Cancer
por: Wan, Guoxing, et al.
Publicado: (2019)

Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma
por: Li, Yong, et al.
Publicado: (2020)

Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation
por: Guo, Wei, et al.
Publicado: (2018)

Enhanced mitochondrial pyruvate transport elicits a robust ROS production to sensitize the antitumor efficacy of interferon-γ in colon cancer
por: Tai, YunYan, et al.
Publicado: (2018)

The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases
por: Tan, Hor-Yue, et al.
Publicado: (2016)

VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
por: Pu, Zhangya, et al.
Publicado: (2022)

Metformin therapy associated with survival benefit in lung cancer patients with diabetes
por: Wan, Guoxing, et al.
Publicado: (2016)

HMGB2 upregulation promotes the progression of hepatocellular carcinoma cells through the activation of ZEB1/vimentin axis
por: Lu, Kai, et al.
Publicado: (2023)

YAP promotes autophagy and progression of gliomas via upregulating HMGB1
por: Zhao, Min, et al.
Publicado: (2021)

Maslinic acid promotes autophagy by disrupting the interaction between Bcl2 and Beclin1 in rat pheochromocytoma PC12 cells
por: Dong, Xiaoli, et al.
Publicado: (2017)

Extracellular HMGB1 exacerbates autoimmune progression and recurrence of type 1 diabetes by impairing regulatory T cell stability
por: Zhang, Jing, et al.
Publicado: (2020)

2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside induces autophagy of liver by activating PI3K/Akt and Erk pathway in prediabetic rats
por: Wang, Xuanbin, et al.
Publicado: (2020)

Inhibition of HMGB1 Suppresses Hepatocellular Carcinoma Progression via HIPK2-Mediated Autophagic Degradation of ZEB1
por: Zhu, Wei, et al.
Publicado: (2021)

The HMGB1 signaling pathway activates the inflammatory response in Schwann cells
por: Man, Li-li, et al.
Publicado: (2015)

CircMMP11 as a prognostic biomarker mediates miR-361-3p/HMGB1 axis to accelerate malignant progression of hepatocellular carcinoma
por: Zou, Qiong, et al.
Publicado: (2023)

Medicinal Plants for the Treatment of Gastrointestinal Cancers From the Metabolomics Perspective
por: Guo, Wei, et al.
Publicado: (2022)

HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin
por: Chen, Mingkun, et al.
Publicado: (2021)

Quality control, preparation process optimizing and anti-inflammatory effects of Premna Puberula Pamp. Pectin
por: Liu, Kaiqi, et al.
Publicado: (2022)

Extracellular HMGB1 promotes CD44 expression in hepatocellular carcinoma via regulating miR-21
por: Li, Jun, et al.
Publicado: (2021)

HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis
por: Shang, Jiawei, et al.
Publicado: (2023)

Fr-HMGB1 and ds-HMGB1 activate the kynurenine pathway via different mechanisms in association with depressive-like behavior
por: Wang, Bo, et al.
Publicado: (2019)

Stratifin Promotes Hepatocellular Carcinoma Progression by Modulating the Wnt/β-Catenin Pathway
por: Ye, Shan-Ping, et al.
Publicado: (2023)

HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer
por: Huang, Bi-Fei, et al.
Publicado: (2018)

Treatment effect of Bushen Huayu extract on postmenopausal osteoporosis in vivo
por: OUYANG, LU, et al.
Publicado: (2014)

Fibroblast growth factor 10 alleviates particulate matter-induced lung injury by inhibiting the HMGB1-TLR4 pathway
por: Liu, Lingjing, et al.
Publicado: (2020)

Glycyrrhizin regulates rat TMJOA progression by inhibiting the HMGB1‐RAGE/TLR4‐NF‐κB/AKT pathway
por: Hu, Zhihui, et al.
Publicado: (2021)

Temozolomide Treatment Induces HMGB1 to Promote the Formation of Glioma Stem Cells via the TLR2/NEAT1/Wnt Pathway in Glioblastoma
por: Gao, Xiang-Yu, et al.
Publicado: (2021)

The progression of HMGB1-induced autophagy in cancer biology
por: Xu, Tianwei, et al.
Publicado: (2018)

Glycyrrhizin mitigates radiation‐induced acute lung injury by inhibiting the HMGB1/TLR4 signalling pathway
por: Zheng, Lei, et al.
Publicado: (2019)

Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1
por: Sun, Yuan-dong, et al.
Publicado: (2021)

Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled Trials
por: Cheung, Fan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9567lc7bjdnitj0vnc7vrmv4vl